mirtazapine has been researched along with Sarcoidosis in 6 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine 15 mg was started while prednisone treatment was continued." | 5.43 | Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis. ( Atzori, C; Bonora, S; Busolli, P; Calcagno, A; Ghisetti, V; Imperiale, D; Trentalange, A, 2016) |
| "Mirtazapine 15 mg was started while prednisone treatment was continued." | 1.43 | Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis. ( Atzori, C; Bonora, S; Busolli, P; Calcagno, A; Ghisetti, V; Imperiale, D; Trentalange, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scholten, P | 1 |
| Kralt, P | 1 |
| Jacobs, B | 1 |
| Trentalange, A | 1 |
| Calcagno, A | 1 |
| Ghisetti, V | 1 |
| Atzori, C | 1 |
| Busolli, P | 1 |
| Bonora, S | 1 |
| Imperiale, D | 1 |
| Pallin, M | 1 |
| O'Sullivan, C | 1 |
| Dodd, JD | 1 |
| McCreery, K | 1 |
| Brett, F | 1 |
| Farrell, M | 1 |
| O'Brien, D | 1 |
| Hall, WW | 1 |
| Tubridy, NJ | 1 |
| Keane, MP | 1 |
| Rath, T | 1 |
| Hackenbroch, M | 1 |
| Saech, J | 1 |
| Hallek, M | 2 |
| Rubbert, A | 2 |
| Hohlfeld, SK | 1 |
| Günthard, HF | 1 |
| Zeitz, J | 1 |
| Locher, P | 1 |
| Bachli, E | 1 |
| Owczarczyk, K | 1 |
| Hilker, R | 1 |
| Brunn, A | 1 |
6 other studies available for mirtazapine and Sarcoidosis
| Article | Year |
|---|---|
Posterior fossa progressive multifocal leukoencephalopathy: first presentation of an unknown autoimmune disease.
Topics: Adrenergic alpha-Antagonists; Cerebellar Ataxia; Disease Progression; Dysarthria; Fatal Outcome; Hum | 2017 |
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
Topics: Aged; DNA, Viral; Female; Humans; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressi | 2016 |
A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis.
Topics: Antimalarials; Antiviral Agents; Biopsy; Brain; Hemianopsia; Histamine H1 Antagonists; Histological | 2012 |
Longterm remission of more than 5 years in a patient with progressive multifocal leucoencephalopathy and sarcoidosis.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Brain; Cidofovir; Cytosine; Female; Gait Disorders, Neur | 2012 |
Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis.
Topics: Adrenergic alpha-Antagonists; Adult; DNA, Viral; Fatal Outcome; Humans; JC Virus; Leukoencephalopath | 2012 |
Progressive multifocal leucoencephalopathy in a patient with sarcoidosis--successful treatment with cidofovir and mirtazapine.
Topics: Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Humans; Leukoencephalopath | 2007 |